Author

A. Hinzpeter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Edelman· 2 shared I. Sermet-Gaudelus· 2 shared A. Delaunay-Moisan· 1 shared A. Golec· 1 shared A. Hadchouel Duverge· 1 shared A. Premchandar· 1 shared B. Chevalier· 1 shared C. Delacourt· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

A. Edelman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Keratin 8 is a scaffolding and regulatory protein of ERAD complexes

I. M. Pranke, B. Chevalier, A. Premchandar, N. Baatallah, K. F. Tomaszewski, S. Bitam, D. Tondelier, A. Golec, J. Stolk, G. L. Lukacs, P. S. Hiemstra, M. Dadlez, D. A. Lomas, J. A. Irving, A. Delaunay-Moisan, , A. Edelman

This study shows that Keratin 8 modulates ERAD complexes, enhancing degradation of misfolded proteins like Z-A1AT and F508del-CFTR, and suggests targeting K8 for therapeutic intervention in A1ATD.

bioRxiv · Feb 1, 2022Cell Biology

Elexacaftor/Tezacaftor/Ivacaftor alters branching morphogenesis of the mouse embryonic lung

M. Lhuillier, L. Aoust, E. Dreano, M.-L. Franco-Montoya, K. Landry-Truchon, N. Houde, S. Chhun, A. Hinzpeter, A. Edelman, C. Delacourt, L. Jeannotte, I. Sermet-Gaudelus, A. Hadchouel Duverge

This paper shows that the triple CFTR modulator therapy ETI reduces lung branching and increases terminal bud dilation in mouse embryos, suggesting potential developmental risks.

bioRxiv · Nov 1, 2021 · PreprintPharmacology & Toxicology